Krittiya Korphaisarn

1.8k total citations
42 papers, 532 citations indexed

About

Krittiya Korphaisarn is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Krittiya Korphaisarn has authored 42 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 16 papers in Pathology and Forensic Medicine and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Krittiya Korphaisarn's work include Colorectal Cancer Treatments and Studies (15 papers), Genetic factors in colorectal cancer (10 papers) and Colorectal and Anal Carcinomas (6 papers). Krittiya Korphaisarn is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), Genetic factors in colorectal cancer (10 papers) and Colorectal and Anal Carcinomas (6 papers). Krittiya Korphaisarn collaborates with scholars based in Thailand, United States and Japan. Krittiya Korphaisarn's co-authors include Scott Kopetz, Charuwan Akewanlop, David G. Menter, Michael J. Overman, Suthinee Ithimakin, Kanwal Raghav, Ananya Pongpaibul, Nopadol Soparattanapaisarn, Jonathan M. Loree and Pongwut Danchaivijitr and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Krittiya Korphaisarn

40 papers receiving 525 citations

Peers

Countries citing papers authored by Krittiya Korphaisarn

Since Specialization

Citations

This map shows the geographic impact of Krittiya Korphaisarn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krittiya Korphaisarn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krittiya Korphaisarn more than expected).

Fields of papers citing papers by Krittiya Korphaisarn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krittiya Korphaisarn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krittiya Korphaisarn. The network helps show where Krittiya Korphaisarn may publish in the future.

Co-authorship network of co-authors of Krittiya Korphaisarn

This figure shows the co-authorship network connecting the top 25 collaborators of Krittiya Korphaisarn. A scholar is included among the top collaborators of Krittiya Korphaisarn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krittiya Korphaisarn. Krittiya Korphaisarn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comprehensive genomic analysis in sporadic early-onset colorectal adenocarcinoma patients 2025 ·BMC Cancer ·Ben Ponvilawan, Phuwanat Sakornsakolpat, Ananya Pongpaibul, (unknown), Charuwan Akewanlop, Manop Pithukpakorn, Krittiya Korphaisarn	1
2	Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 Trial 2025 ·JCO Precision Oncology ·Sun Young Rha, Yanqiao Zhang, Anneli Elme, Roberto Pazo-Cid, Ahmet Alacacıoğlu, Dimitrios C. Ziogas, Kohei Shitara, (unknown), Radim Němeček, Armando Santoro, (unknown), Krittiya Korphaisarn, Thomas R. A. Davis, (unknown), (unknown), Mengyao Tan, (unknown), Zev A. Wainberg	8
3	Comprehensive germline and somatic profiling of high-risk Thai breast cancer via next-generation sequencing 2025 ·Scientific Reports ·(unknown), (unknown), Wanna Thongnoppakhun, Krittiya Korphaisarn, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Manop Pithukpakorn, Bhoom Suktitipat	0
4	1206MO ALINA: Exploratory biomarker analyses in patients (pts) with resected ALK+ non-small cell lung cancer (NSCLC) treated with adjuvant alectinib vs chemotherapy (chemo) 2024 ·Annals of Oncology ·Benjamin Solomon, Yi‐Long Wu, Rafał Dziadziuszko, Fabrice Barlési, Makoto Nishio, (unknown), Hidehito Horinouchi, Maximilian J. Hochmair, Filippo de Marinis, M.R. Migliorino, (unknown), Hakan Harputluoğlu, (unknown), Krittiya Korphaisarn, (unknown), T Lohmann, (unknown), V.R. Archer, Małgorzata Nowicka, Johannes Noé	1
5	Dietary pattern and the corresponding gut microbiome in response to immunotherapy in Thai patients with advanced non-small cell lung cancer (NSCLC) 2024 ·Scientific Reports ·Piyada Sitthideatphaiboon, (unknown), (unknown), (unknown), Narittee Sukswai, Krittiya Korphaisarn, Naravat Poungvarin, Chatchawit Aporntewan, Nattiya Hirankarn, Chanida Vinayanuwattikun, (unknown)	7
6	Dietary pattern and the corresponding gut microbiome in response to immunotherapy in Thai patients with advanced non-small cell lung cancer (NSCLC). 2024 ·Journal of Clinical Oncology ·Piyada Sitthideatphaiboon, (unknown), (unknown), (unknown), Narittee Sukswai, Krittiya Korphaisarn, Naravat Poungvarin, Chatchawit Aporntewan, Nattiya Hirankarn, Chanida Vinayanuwattikun	1
7	Cost–Utility and Budget Impact Analyses of Oral Chemotherapy for Stage III Colorectal Cancer: Real-World Evidence after Policy Implementation in Thailand 2023 ·Cancers ·Pochamana Phisalprapa, (unknown), Krittiya Korphaisarn, Charuwan Akewanlop, Vichien Srimuninnimit, Siripen Supakankunti, (unknown), Nathorn Chaiyakunapruk	1
8	The KRAS-Mutant Consensus Molecular Subtype 3 Reveals an Immunosuppressive Tumor Microenvironment in Colorectal Cancer 2023 ·Cancers ·(unknown), Amphun Chaiboonchoe, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bhoom Suktitipat, Somponnat Sampattavanich, Krittiya Korphaisarn, Ananya Pongpaibul, Naravat Poungvarin, Harald Grove, (unknown), Atthaphorn Trakarnsanga, (unknown), Manop Pithukpakorn, Vitoon Chinswangwatanakul	14
9	1302P Treatment outcomes and safety of durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in Thai populations: A real-world, multi-center observational study 2023 ·Annals of Oncology ·Piyada Sitthideatphaiboon, Thanyanan Reungwetwattana, (unknown), (unknown), (unknown), Kunlatida Maneenil, Krittiya Korphaisarn, (unknown), (unknown), (unknown), (unknown), (unknown), Naiyarat Prasongsook, Virote Sriuranpong	0
10	LBA1 Efficacy and safety of adjuvant alectinib vs platinum-based chemotherapy (CT) in patients (pts) from Asia with resected, early-stage ALK+ non-small cell lung cancer (NSCLC): A sub analysis of ALINA 2023 ·Annals of Oncology ·Jin Seok Ahn, Yi‐Long Wu, Rafał Dziadziuszko, Fabrice Barlési, Makoto Nishio, Daniel Lee, Jin Sun Lee, (unknown), Hidehito Horinouchi, Weimin Mao, Shun Lü, Qun Wang, Cheng‐Ta Yang, Krittiya Korphaisarn, Tao Xu, (unknown), Astrid Scalori, (unknown), (unknown), Benjamin Solomon	2
11	Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer 2022 ·Scientific Reports ·Piyada Sitthideatphaiboon, (unknown), Krittiya Korphaisarn, (unknown), (unknown), Naravat Poungvarin, (unknown), Shanop Shuangshoti, Chatchawit Aporntewan, (unknown), Virote Sriuranpong, Chanida Vinayanuwattikun	21
12	MO5-3 Efficacy and patient-report outcomes of atezolizumab/ bevacizumab for unresectable hepatocellular carcinoma in Thailand 2022 ·Annals of Oncology ·(unknown), Suebpong Tanasanvimon, Krittiya Korphaisarn, (unknown), (unknown), Jitlada Juengsamarn, (unknown), Jarin Chindaprasirt, Naiyarat Prasongsook, (unknown), (unknown), Nuttapong Ngamphaiboon, Ekaphop Sirachainan	1
13	Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma 2022 ·Frontiers in Oncology ·(unknown), (unknown), Ben Ponvilawan, (unknown), (unknown), Amphun Chaiboonchoe, (unknown), (unknown), (unknown), (unknown), Krittiya Korphaisarn, Seiji Okada, Somponnat Sampattavanich, Siwanon Jirawatnotai	12
14	The Acquired Vulnerability Caused by CDK4/6 Inhibition Promotes Drug Synergism Between Oxaliplatin and Palbociclib in Cholangiocarcinoma 2022 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), Ben Ponvilawan, (unknown), (unknown), Krittiya Korphaisarn, Komgrid Charngkaew, (unknown), Trairak Pisitkun, Seiji Okada, Somponnat Sampattavanich, Siwanon Jirawatnotai	9
15	Effect of Primary Tumor Location on Second- or Later-Line Treatment With Anti-Epidermal Growth Factor Receptor Antibodies in Patients With Metastatic Colorectal Cancer: A Retrospective Multi-Center Study 2022 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), Naravat Poungvarin, Suebpong Tanasanvimon, Ekaphop Sirachainan, Charuwan Akewanlop, Krittiya Korphaisarn	3
16	Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study 2021 ·Frontiers in Oncology ·Krittiya Korphaisarn, Pongwut Danchaivijitr, Thanyanan Reungwetwattana, (unknown), (unknown), Jarin Chindaprasirt, Kunlatida Maneenil, (unknown), Chanida Vinayanuwattikun	5
17	Clinicopathological Characteristics and Outcome of Adolescent and Young Adult-Onset Microsatellite Stable Colorectal Cancer Patients 2020 ·Journal of Adolescent and Young Adult Oncology ·(unknown), Ananya Pongpaibul, (unknown), Charuwan Akewanlop, Krittiya Korphaisarn	6
18	Randomized, double-blind, placebo-controlled study of aprepitant versus two dosages of olanzapine with ondansetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving high-emetogenic chemotherapy 2020 ·Supportive Care in Cancer ·Suthinee Ithimakin, (unknown), (unknown), (unknown), Charuwan Akewanlop, Nopadol Soparattanapaisarn, (unknown), Krittiya Korphaisarn, Pongwut Danchaivijitr	20
19	Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer 2019 ·BMC Cancer ·Shailesh Advani, (unknown), Derek W. Brown, Stacia M. DeSantis, Krittiya Korphaisarn, Helena M. VonVille, Jan Bressler, David S. López, Jennifer S. Davis, Carrie R. Daniel, Amir Mehrvarz Sarshekeh, Dejana Braithwaite, Michael D. Swartz, Scott Kopetz	22
20	Effectiveness of direct observation and supervision at out-patient setting on improving clinical skills of medical students. 2014 ·PubMed ·(unknown), Praveena Chiowchanwisawakit, Krittiya Korphaisarn, Ranistha Ratanarat, Varalak Srinonprasert	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact